We scoured the nation to identify the best stock in every state. AmerisourceBergen (symbol ABC) is the publicly traded company we picked in Pennsylvania. The company headquarters is located in Chesterbrook.
A word of caution: Since we selected a single stock from each state (plus one from D.C), and choices in some states are sparse, a few of our picks are best suited to investors comfortable with a higher degree of risk. This is not necessarily one of our 51 favorite stocks in the entire U.S., in other words.
AmerisourceBergen by the Numbers
- Headquarters: Chesterbrook
- Share price: $96.37
- Market value: $21.0 billion
- Price-earnings ratio: 16
(Prices and data are as of June 22, 2017)
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
AmerisourceBergen is one of three major U.S. pharmaceutical distributors, and it is the main supplier to Walgreens and Express Scripts. The company’s partnership with Walgreens includes supplying the retailer’s entire drug inventory, including generics. Given its high profit margins, the generics business is a major driver of the company’s overall profitability, says Morningstar analyst Vishnu Lekraj. Due to the company’s enormous scale and its status as a preferred partner among drug manufacturers and retail pharmacies, he says, Amerisource will play a critical role in the pharmaceutical supply chain for years to come. That means it stands to benefit from an aging population and a raft of new generic drugs hitting the market as pharmaceutical patents expire, says CFRA analyst Joseph Agnese. He rates the stock a “buy” and believes its shares can hit $99 over the next 12 months.
-
Small Businesses Are Racing to Use AIThe Kiplinger Letter Spurred on by competitive pressures, small businesses are racing to adopt AI. A recent snapshot shows the technology’s day-to-day uses.
-
The Me-First Rule of Retirement SpendingFollow the 'Me-First" rule and you won't have to worry about running out of money when the stock market goes south.
-
If You'd Put $1,000 Into Sherwin-Williams Stock 20 Years Ago, Here's What You'd Have TodaySherwin-Williams stock has clobbered the broader market by a wide margin for a long time.
-
If You'd Put $1,000 Into UnitedHealth Group Stock 20 Years Ago, Here's What You'd Have TodayUNH stock was a massive market beater for ages — until it wasn't.
-
If You'd Put $1,000 Into Berkshire Hathaway Stock 20 Years Ago, Here's What You'd Have TodayBerkshire Hathaway is a long-time market beater, but the easy money in BRK.B has already been made.
-
If You'd Put $1,000 Into Procter & Gamble Stock 20 Years Ago, Here's What You'd Have TodayProcter & Gamble stock is a dependable dividend grower, but a disappointing long-term holding.
-
My Three-Day Rule for Investing: And If it Applies NowStock Market I've seen a lot in my career. Here's what I see now in the stock market.
-
Is It Time to Invest in Europe?Stock Market Europe is being shaken out of its lethargy, militarily and otherwise, by Donald Trump's changes in U.S. policy. Should investors start buying?
-
Why Is Warren Buffett Selling So Much Stock?Berkshire Hathaway is dumping equities, hoarding cash and making market participants nervous.
-
If You'd Put $1,000 Into Google Stock 20 Years Ago, Here's What You'd Have TodayGoogle parent Alphabet has been a market-beating machine for ages.
